The Vanderbilt Atrial Fibrillation Ablation Registry
| Status: | Recruiting |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/3/2018 |
| Start Date: | October 2011 |
| End Date: | October 2021 |
| Contact: | Moore B Shoemaker, MD, MSCI |
| Phone: | 615 322 |
The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and
genetic biorepository that systematically enrolls patients undergoing atrial fibrillation
(AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records
with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic,
and serological predictors of response to AF ablation in order to improve patient selection,
and 2) to provide a resource for translational research investigating the electrophysiologic
mechanisms of AF pathogenesis.
genetic biorepository that systematically enrolls patients undergoing atrial fibrillation
(AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records
with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic,
and serological predictors of response to AF ablation in order to improve patient selection,
and 2) to provide a resource for translational research investigating the electrophysiologic
mechanisms of AF pathogenesis.
The study population consists of patients at least 18 years of age who are scheduled for AF
ablation at Vanderbilt University. Data recorded at enrollment includes a detailed past
medical history and measurements from pre-ablation imaging (cardiac MRI or CT). At the time
of ablation, a blood sample is collected for storage of plasma/serum and extraction of DNA,
and details of the ablation procedure are recorded. Post-ablation monitoring for arrhythmia
recurrence is performed according to a standard clinical follow-up schedule at 3, 6, and
12-months. ECG's are performed at each follow-up visit along with placement of an ambulatory
ECG-monitor. At 6-months post-ablation, cardiac imaging with a repeat cardiac MRI or CT is
performed.
ablation at Vanderbilt University. Data recorded at enrollment includes a detailed past
medical history and measurements from pre-ablation imaging (cardiac MRI or CT). At the time
of ablation, a blood sample is collected for storage of plasma/serum and extraction of DNA,
and details of the ablation procedure are recorded. Post-ablation monitoring for arrhythmia
recurrence is performed according to a standard clinical follow-up schedule at 3, 6, and
12-months. ECG's are performed at each follow-up visit along with placement of an ambulatory
ECG-monitor. At 6-months post-ablation, cardiac imaging with a repeat cardiac MRI or CT is
performed.
Inclusion criteria:
1. Age >18 years
2. Able to give written, informed consent
3. Scheduled for an ablation procedure to treat atrial fibrillation
Exclusion criteria:
1. None
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Moore B Shoemaker, MD, MSCI
Phone: 615-936-6069
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
